Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.

Pauline Wils (1) , Yoram Bouhnik (2) , Bernard Flourie (3) , Hédia Brixi (4) , Jacques Cosnes (5) , Matthieu Allez (6) , Bernard Duclos (7) , Pierre Michetti (8) , Jean-Charles Grimaud (9) , Gilles Bommelaer (10) , Aurélien Amiot (11) , Mathurin Fumery (12) , Jérôme Filippi (13) , Vered Abitbol (14) , Benoit Coffin (15) , Marion Simon (16) , David Laharie (17) , Benjamin Pariente (1)

1 Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille]
2 Service de Gastroentérologie [Hôpital Beaujon]
3 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
4 Hôpital universitaire Robert Debré [Reims]
5 CHU Saint-Antoine [AP-HP]
6 AP-HP - Hopital Saint-Louis [AP-HP]
7 CHU Strasbourg - Centre Hospitalier Universitaire [Strasbourg]
8 CHUV - Centre Hospitalier Universitaire Vaudois = Lausanne University Hospital [Lausanne]
9 Hôpital Nord [CHU - APHM]
10 CHU Clermont-Ferrand
11 Service de gastro-entérologie [Henri Mondor AP-HP, Créteil]
12 Service d'Hépato Gastroenterologie [CHU Amiens-Picardie]
13 CHU Nice - Centre Hospitalier Universitaire de Nice
14 Service de Gastro-entérologie [CHU Cochin]
15 Hôpital Louis Mourier - AP-HP [Colombes]
16 IMM - Institut Mutualiste de Montsouris
17 CHU Bordeaux

Domaines: Hépatologie et Gastroentérologie

Pauline Wils, Yoram Bouhnik, Bernard Flourie, Hédia Brixi, Jacques Cosnes, et al.. Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.. 10. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2015, Barcelone, Spain. pp.S37-S39, ⟨10.1093/ecco-jcc/jju027.057⟩. ⟨hal-03553426⟩